544 F.3d 1323 (Fed. Cir. 2008), 2008-1097, In re Ciprofloxacin Hydrochloride Antitrust Litigation
Linked as:
Extract
544 F.3d 1323 (Fed. Cir. 2008), 2008-1097, In re Ciprofloxacin Hydrochloride Antitrust Litigation
No longer available (Autolink)
See the full content of this document
This document cites
- US Code - 35 U.S.C. § 101 Inventions Patentable
- US Code - 35 U.S.C. § 103 Conditions For Patentability; Non-Obvious Subject Matter
- US Code - 35 U.S.C. § 154 Contents and Term of Patent; Provisional Rights
- US Code - 35 U.S.C. § 282 Presumption of Validity; Defenses
- Code of Federal Regulations - Date of approval of a 505(b)(2) application or ANDA